ImmuCell
ICCC
30 hedge funds and large institutions have $5.42M invested in ImmuCell in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 25 → 30 (+5)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
8% more capital invested
Capital invested by funds: $5.03M → $5.42M (+$398K)
1.77% more ownership
Funds ownership: 11.87% → 13.64% (+1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 2 |
PP
Prosperity Planning
Kansas City,
Missouri
|
+$104K |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$26.5K |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$17.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$35.7K |
| 2 |
OMC
Overbrook Management Corp
New York
|
-$17.4K |
| 3 |
Renaissance Technologies
New York
|
-$17.3K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$2.11K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$188 |
ICCC Hedge Fund Activity: Q1 2023 in Review
30 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2023, worth a combined $5.42M — up 7.9% from $5.03M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ICCC positions and 0 closed out — a net gain of 5 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was Morgan Stanley, cutting an estimated $35.7K.
- 30 institutional investors held ImmuCell (ICCC) as of Q1 2023, up from 25 in Q4 2022.
- Funds reported $5.42M of ImmuCell stock for Q1 2023, up 7.9% quarter-over-quarter.
- 5 funds opened new ImmuCell positions in Q1 2023 and 0 closed out, a net change of +5 holders.
- The largest ImmuCell buyer in Q1 2023 was Citadel Advisors, an estimated $110K added.
- The largest ImmuCell seller in Q1 2023 was Morgan Stanley, an estimated $35.7K sold.
Based on aggregated 13F filings for Q1 2023.